DDL 2022

H&T Presspart, a specialist manufacture of respiratory drug-delivery systems and pharmaceutical components, is pleased to announce we will be a Silver Sponsor of this year’s Drug Delivery to the Lungs (DDL) conference in Edinburgh from 7-9 December 2022.

We are extremely excited to welcome our industry colleagues and friends back to DDL which will be the first face to face conference since 2019.

During the conference H&T Presspart will be showcasing our full range of respiratory drug delivery components and devices including MDI cans and actuators, dose counting solutions, as well as our range of DPIs in the exhibition hall.

Visitors to the stand can also find out more about our plasma treatment process which improves the internal surface energy performance of an MDI canister, and helps stop drug degradation or adhesion inside the can, ensuring the patient gets the correct dose every time.

In addition, our sales and business development team will be on hand at the show to discuss all things drug delivery and answer any questions or queries you may have.

If you would like to get in touch with any questions about the event or to organise a meeting during DDL2022, please contact the team.

We look forward to seeing everyone in December!